Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer

BACKGROUND: Molecular tumour boards (MTB) optimally match oncological therapies to patients with genetic aberrations. Prostate cancer (PCa) is underrepresented in these MTB discussions. This study describes the impact of routine genetic profiling and MTB referral on the outcome of PCa patients in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Slootbeek, Peter H. J., Kloots, Iris S. H., Smits, Minke, van Oort, Inge M., Gerritsen, Winald R., Schalken, Jack A., Ligtenberg, Marjolijn J. L., Grünberg, Katrien, Kroeze, Leonie I., Bloemendal, Haiko J., Mehra, Niven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927341/
https://www.ncbi.nlm.nih.gov/pubmed/34912074
http://dx.doi.org/10.1038/s41416-021-01663-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8927341/
https://www.ncbi.nlm.nih.gov/pubmed/34912074
http://dx.doi.org/10.1038/s41416-021-01663-9

Ejemplares similares